Literature DB >> 30452406

Use of RBC deformability index as an early marker of diabetic nephropathy.

Sang Bae Lee1, Yu-Sik Kim2, Jung Hye Kim1, Kahui Park1, Ji Sun Nam1,2, Shinae Kang1,2, Jong Suk Park1,2, Sehyun Shin3, Chul Woo Ahn1,2.   

Abstract

BACKGROUND AND
OBJECTIVE: Hemorheologic alterations have been suggested to play a role in the pathogenesis of diabetic microvascular complications. We measured various hemorheologic parameters and assessed their possible role as a diagnostic tool for diabetic nephropathy (DN).
METHODS: 248 subjects with type 2 diabetes and 222 subjects with prediabetes were included in this study. Hemorheologic parameters, including erythrocyte sedimentation rate (ESR), elongation index at 3 Pa (EI) were measured using microfluidic hemorheometer. Various metabolic parameters were measured from fasting blood samples. The subjects were stratified into three groups according to classification of DN by urinary albumin to creatinine ratio (ACR) and four groups by estimated glomerular filtration rate (GFR), than analyzed.
RESULTS: Significant differences were observed in metabolic and hemorheologic parameters according to progression of DN. Among them, (Fibrinogen×ESR)/ EI differed in all three groups of urinary ACR. In multiple regression analysis, (Fibrinogen×ESR)/ EI was an independent predictor of urine ACR after adjusted with confounding factors (ß  = 0.010, p < 0.001). (Fibrinogen×ESR)/ EI also showed significant difference no or minimal CKD stage, moderate CKD and severe CKD classified by GFR. This parameter showed area under curve (AUC) of the receiver operating characteristic (ROC) curve of 0.762, and moderate sensitivity and specificity to predict prevalence of microalbuminuria.
CONCLUSIONS: (Fibrinogen×ESR)/ EI is a sensitive parameter for screening diabetic nephropathy.

Entities:  

Keywords:  Diabetic nephropathy; RBC deformability; elongation index; hemorheology

Mesh:

Year:  2019        PMID: 30452406     DOI: 10.3233/CH-180434

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  7 in total

1.  A New In Vitro Blood Hyperviscosity Model.

Authors:  A V Sidekhmenova; O I Aliev; N S Domnina; P S Vlasov; E V Popova; M B Plotnikov
Journal:  Bull Exp Biol Med       Date:  2022-02-17       Impact factor: 0.804

2.  Use of haematological signatures in conjunction with conventional biomarkers to assess Reno-protective effects of Gedunin in diabetic nephropathy of Streptozotocin induced diabetic rats.

Authors:  Suchismita Mazumdar; Thankamani Marar; Jyoti Patki
Journal:  J Diabetes Metab Disord       Date:  2022-01-20

Review 3.  Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes.

Authors:  Hoyoon Lee; Wonwhi Na; Sang Bae Lee; Chul Woo Ahn; Jun Sung Moon; Kyu Chang Won; Sehyun Shin
Journal:  Front Physiol       Date:  2019-08-20       Impact factor: 4.566

Review 4.  The Relationship between Erythrocytes and Diabetes Mellitus.

Authors:  Yaqi Wang; Peiyuan Yang; Zhaoli Yan; Zhi Liu; Qiang Ma; Zehong Zhang; Yunxia Wang; Yan Su
Journal:  J Diabetes Res       Date:  2021-02-25       Impact factor: 4.011

Review 5.  Erythrocyte Deformability and Na,K-ATPase Activity in Various Pathophysiological Situations and Their Protection by Selected Nutritional Antioxidants in Humans.

Authors:  Jana Radosinska; Norbert Vrbjar
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

6.  Critical shear stress of red blood cells as a novel integrated biomarker for screening chronic kidney diseases in cases of type 2 diabetes.

Authors:  Il Rae Park; Jimi Choi; Eun Young Ha; Seung Min Chung; Jun Sung Moon; Sehyun Shin; Sin Gon Kim; Kyu Chang Won
Journal:  Clin Hemorheol Microcirc       Date:  2022       Impact factor: 2.411

7.  Prevention of tubulin/aldose reductase association delays the development of pathological complications in diabetic rats.

Authors:  Juan F Rivelli Antonelli; Verónica S Santander; Ayelen D Nigra; Noelia E Monesterolo; Gabriela Previtali; Emilianao Primo; Lisandro H Otero; César H Casale
Journal:  J Physiol Biochem       Date:  2021-06-07       Impact factor: 4.158

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.